These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36376963)

  • 1. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
    Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
    Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
    Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ
    J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter
    Rullmann M; Brendel M; Schroeter ML; Saur D; Levin J; Perneczky RG; Tiepolt S; Patt M; Mueller A; Villemagne VL; Classen J; Stephens AW; Sabri O; Barthel H; On Behalf Of The German Imaging Initiative For Tauopathies Gii T
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
    JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
    Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
    Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
    Koychev I; Hofer M; Friedman N
    J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Moloney CM; Labuzan SA; Crook JE; Siddiqui H; Castanedes-Casey M; Lachner C; Petersen RC; Duara R; Graff-Radford NR; Dickson DW; Mielke MM; Murray ME
    Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
    Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
    Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study.
    Plowey ED; Ziskin JL
    Acta Neuropathol Commun; 2016 Oct; 4(1):114. PubMed ID: 27793193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
    Arezoumandan S; Xie SX; Cousins KAQ; Mechanic-Hamilton DJ; Peterson CS; Huang CY; Ohm DT; Ittyerah R; McMillan CT; Wolk DA; Yushkevich P; Trojanowski JQ; Lee EB; Grossman M; Phillips JS; Irwin DJ
    Acta Neuropathol; 2022 Dec; 144(6):1103-1116. PubMed ID: 35871112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.